FUTURE PATENT APPLICATIONS Sample Clauses
The "Future Patent Applications" clause defines how rights and obligations regarding patents that may be filed after the agreement’s effective date are handled between the parties. Typically, this clause specifies whether inventions or improvements developed during the course of the agreement must be disclosed, and who will own or have the right to use any resulting patents. For example, it may require one party to assign any future patent rights to the other, or to grant a license for any such patents. The core function of this clause is to prevent disputes over ownership or use of intellectual property that arises from ongoing collaboration, ensuring that both parties have clear expectations about future innovations.
POPULAR SAMPLE Copied 1 times
FUTURE PATENT APPLICATIONS. All U.S. and foreign patent applications, developed jointly or independently by either party, which may or may not be related to the above-listed Issued Patents and Pending Patent Applications, but which disclose subject matter encompassed within the Field.
FUTURE PATENT APPLICATIONS. Essential Innovations shall be entitled to apply for any patents related to the utilization of the Technology for any/all unique external applications it may uncover whether as previously defined or whether deemed to be different than those for which Essential and the Inventor have filed their initial patent. Having said that, Essential Innovations agrees to always include the inventor in any patent that Essential Innovations may file of it’s own accord in the future where the Assigned Technology has been used somewhere in the patent in whole or in part.
FUTURE PATENT APPLICATIONS. All U.S. and foreign patent applications, including continuations, divisionals, re-exams, reissues and continuations-in-part, and any other forms of related applications, that claim domestic or international priority to any of the issued United States or foreign patents, or pending United States, international, or foreign patent applications, specifically listed by patent or application number in Section 2.3.
FUTURE PATENT APPLICATIONS. (a) With respect to any PATENT APPLICATION for existing sole inventions in the FIELD owned, licensed to or controlled by InSite that are filed in the future:
(i) InSite shall remain the owner of each such sole invention subject to such PATENT APPLICATION.
(ii) If, anywhere in the TERRITORY, InSite determines to file a PATENT APPLICATION for an invention covering the use of the COMPOUND in the FIELD, then (A) InSite will prepare a first draft of the application and furnish a copy of the draft to the DC or P&U, as applicable, for comment at least 30 days before filing the application, (B) InSite will reasonably consider all revisions as requested by the DC or P&U, as applicable, and file the application in each country in which the DC or P&U, as applicable, elects to do so, (C) InSite will bear the full costs of preparing, filing and prosecuting the application and InSite will control the prosecution of the application, (D) in any country in which InSite elects not to file the application, P&U may file the application at its own cost and control the prosecution thereof (in which event it will keep the DC, if applicable, reasonably informed of the application's progress), and (E) each application and any patents issuing thereon filed by InSite will constitute INSITE PATENT RIGHTS for purposes of this Agreement.
(iii) If InSite elects not to file a PATENT APPLICATION covering an invention covering the use of the COMPOUND in the FIELD anywhere in the world, then (A) the invention will remain a trade secret of InSite (unless (C) below becomes applicable), (B) if the invention constitutes INSITE KNOW-HOW, it will be subject to the same provisions as other INSITE KNOW-HOW (unless (C) below becomes applicable), and (C) P&U shall have the right to cause InSite to file such PATENT APPLICATIONS for the invention, at P&U's sole cost and expense, anywhere in the world, with all rights in such PATENT APPLICATION and any resulting PATENT being assigned by InSite to P&U, without the payment of any consideration.
FUTURE PATENT APPLICATIONS. DISTRIBUTOR shall not be entitled to apply for any or claim any patents or any other intellectual property protection or ownership related to the utilization of the Technology IP for any/all unique external applications it may uncover whether as previously defined or whether deemed to be different than those for which Distributor and the Technology Holder may have had any prior discussions. The Distributor irrevocably agrees and undertakes always to inform the Technology Holder of any patent or other intellectual property that the Distributor may conceive, discover or produce and assign any such rights to the Technology Holder without payment or encumbrance.
i) Technology Holder warrants, represents and covenants with Distributor that the Technology Holder is the owner of the SayberX technology and technical information, theory, knowledge, process and expertise concerning the design, construction and use of the technology and that it has the right to grant the this Distribution license for the Technology IP to the Distributor.
ii) Any modification, improvement or variance of the Technology IP which is patentable or subject to any other intellectual property protection may be protected by the Technology Holder but such application and any subsequent protection shall form part of the Technology IP.
FUTURE PATENT APPLICATIONS. Tristar shall have the right, but not the obligation, to prosecute any patent application, United States and foreign, for the Product, in National Boston's name and on behalf of National Boston with National Boston's prior written approval, and National Boston shall cooperate fully with Tristar with respect thereto, but all of such activity shall be at the sole cost and expense of Tristar. Tristar shall have no liability under any circumstances to National Boston for any decision or failure by Tristar to apply for such patents or for any action, activity, neglect or failure by Tristar, its representatives and agents, in connection therewith.
FUTURE PATENT APPLICATIONS. As derived from the above patents and/or patent applications and/or from the Confidential Prostagenies Information.